Abstract: Complementary and integrative medicine (CIM) has been used for improving health-related quality of life (HRQOL) in patients with cancer. The objective of this review is to evaluate the effects of CIMs on the HRQOL of cancer patients. We identified randomized controlled trials (RCTs) involving patients with cancer at any stage by retrieving electronic databases from the inception to February 14, 2018 (Systematic Review Registration: PROSPERO CRD42018091609). The main outcomes were HRQOL scores and related domains such as physical well-being scores. The standardized mean difference was used for the analysis and heterogeneity was assessed with the I 2 statistic. A Bayesian framework was used to estimate the ranking order of efficacy in HRQOL change. Finally, 34 RCTs with 3,010 patients were included. As a whole, the results showed clearly superior efficacy of CIM in improving HRQOL. For different domains of HRQOL, different CIM interventions may play different roles. The ranking order of efficacy in change HRQOL was qigong plus mindfulness, Chinese herbal medicine, multimodal complementary medicine, qigong, nutritional supplement, mindfulness, acupuncture, yoga, and massage, and it was different among different domains. There was no evidence of publication bias. In conclusion, CIM may improve the HRQOL of cancer patients. More studies, especially focusing on male cancer patients, are needed to increase the confidence level of our findings.
Introduction
Data from GLOBOCAN 2012, produced by the International Agency for Research on Cancer, indicated that an estimated 14.1 million new cancer cases and 8.2 million cancer deaths occurred in 2012 worldwide. 1 This trend has not been curbed by the progress of medical research. Because low health-related quality of life (HRQOL), especially resulting from inadequate treatment (eg, chemotherapy), may deteriorate cancer patients' condition and even increase mortality, 2 the HRQOL is a central consideration for many physicians in their decision-making process in catering to different treatment options. 3, 4 Identifying the efficacy of long-term treatment strategies in improving low HRQOL in patients with cancer is of paramount importance.
Complementary and integrative medicine (CIM), according to the National Center for Complementary and Integrative Health, refers to the non-mainstream therapies which can be used along with conventional treatment. In general, it encompasses many diverse therapies including natural products (such as herbs and botanicals), mind and body practices (such as acupuncture, massage and mediation), and other complementary health approaches. 5 With more interest in CIM and a growing body of evidence supporting the use of CIM among patients with cancer, more medical clinics and cancer centers are trying to address public interest and demand by providing CIM services. [6] [7] [8] Unfortunately, many integrative practices remain under study, with insufficient evidence to be definitively recommended. The best CIM method for cancer patients has not yet been established. Therefore, in the present systematic review, we examined the randomized clinical trial (RCT) evidence to compare the relative efficacy of different CIM interventions, hoping to provide significant information for patients, health-care practitioners, and policy makers on the course of tumor treatment prescription to treat low HRQOL in patients with cancer.
Materials and methods
We followed the PRISMA guidelines for this systematic review and meta-analysis. 9 A previously established protocol registered with PROSPERO (CRD42018091609) was conducted and associations of each CIM with HRQOL were compared using a direct meta-analysis and Bayesian network meta-analysis. Good research practices on indirect treatment comparisons, as emphasized in the International Society for Pharmacoeconomics and Outcomes Research Task Force, were rigorously followed 10, 11 and quality of evidence was appraised by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. 12 
Search strategy and selection criteria
We searched PubMed, MEDLINE, Embase, Web of Science, Cochrane Central, and Clinical Trial registries (http://www.clinicaltrials.gov and http://www.clinicaltrials register.eu) from inception to February 14, 2018 . We also manually screened published systematic reviews and presentations from major conference proceedings such as the American Society of Clinical Oncology for additional studies. The references of the final included articles were also reviewed. The search was conducted by two investigators (MFZ and WFL) independently. The search terms were "CIM", "complementary and integrative medicine", "complementary and alternative therapies", "complementary medicine", "alternative medicine", "integrative medicine", "HRQOL", "quality of life", "health related quality of life", "life quality", "neoplasia", "tumor", "cancer", "malignant neoplasm", "oncology", "onco*", and "integrative oncology".
To be eligible, RCTs comparing CIM-based intervention with a control group receiving no intervention for psychological functioning and HRQOL in patients with cancer were included. In addition, selected evaluation tools for overall HRQOL were those HRQOL questionnaires which were most widely used in clinical research, including the Functional Assessment of Cancer Therapy (FACT), 13 Functional Assessment of Chronic Illness Therapy (FACIT), 14 MD Anderson Symptom Inventory (MDASI), 15 36-item Short Form Health Survey 36 (SF-36), 16 and European Organisation for Research and Treatment of Cancer (EORTC). 17 We excluded observational studies, trials with unclear effective CIM treatments (eg, music therapy and aromatherapy), and studies conducted in special populations (eg, patients with mental illness or care), to avoid excessive heterogeneity.
Data abstraction and quality assessment
Data from the included studies were extracted by two authors (YRZ and HW) independently on to a standardized form including the name of study, first author, study design, and blinding; patient characteristics; and the frequency, duration, and schedule of the primary intervention. The primary outcome was the HRQOL score changes between baseline and after treatment, which were measured in terms of several multidimensional generic questionnaires consisting of multiple domains such as physical well-being, social well-being, emotional wellbeing, sleep quality, and fatigue. All data were abstracted using study-reported modified intention-to-treat analysis. Data abstraction discrepancies were resolved by consensus in consultation with a third reviewer (ZHZ). The risk of bias of an individual study was assessed in the context of the primary outcome using the Cochrane Risk of Bias assessment tool. 18 
Quality of evidence
We assessed the quality of evidence of estimates derived from network meta-analysis using the GRADE methodology. 12, 19 For direct comparisons in this system, RCTs start at high quality and may be downgraded to levels of moderate, low, and very low quality owing to heterogeneity, risk of bias, indirectness, imprecision, and/ or publication bias. For the indirect estimates, it starts at the lowest rating of the two pairwise estimates that contribute as first-order loops, but may be further downgraded in consideration of imprecision or intransitivity (heterogeneity such as different clinical or methodological characteristics). The higher rating of the direct or indirect estimates would be applied to the network meta-analysis if their ratings were similar.
Statistical analysis
The DerSimonian and Laird random-effects model was used for direct meta-analysis to estimate pooled standardized mean differences (SMDs) and 95% CI incorporating within-and between-study heterogeneity. 20 The I 2 statistic was calculated to assess study heterogeneity. 21 The
Hartung-Knapp method was used to address possible type I errors in post-hoc sensitivity analyses. 22 Funnelplot symmetry and Egger's regression test were used to assess the publication bias, with the test value P<0.05 indicating publication bias. 23 For the indirect meta-analysis, we performed a random-effects network meta-analysis in ADDIS version 1.14.1. Network meta-analysis models in ADDIS are implemented in the Bayesian framework and estimated using Markov chain Monte Carlo (MCMC) methods. 24 This approach is recommended by the National Institute for Health and Care Excellence (NICE) Decision Support Unit technical support documents on evidence synthesis. 25 Since this network meta-analysis is an indirect comparison based on the comparison of placebo/conventional care without CIM and multiple CIMs, statistical analysis is performed directly under the consistency model without the need to carry out consistent tests. Statistical significance was assessed using 95% CI, with CI spanning 1 indicating P>0.05, suggesting no statistical significance. Then, a network diagram was drawn and finally a rankorder graph of each CIM was constructed.
Results

Characteristics of the included studies
In total, 574 unique studies were found using the search strategy, most of which were duplicate records or not reporting RCTs. Thus, 149 full-text articles were fully reviewed according to the inclusion and exclusion criteria, resulting in a final sample of 34 studies (Figure 1 ). All studies are two-arm trials, in which one arm is a CIM intervention, including yoga (eight trials), nutritional supplement (NS) (six trials), Chinese herbal medicine (CH) (four trials), acupuncture (four trials), multimodal complementary medicine (MCM) (three trials), qigong (three trials), mindfulness (MM) (three trials), massage (two trials), or qigong plus MM (one trial), while the other arm is placebo or usual care without CIM treatment.
The characteristics of patients included in the RCTs enrolled in this review are summarized in Table 1 . Overall, these 34 trials were reported between 2006 and 2017 and included 3,010 participants (the range of size of trials was 13 to 275 participants). The primary outcome (HRQOL score changes) was reported in all studies. Among the trials, 16 trials were from the USA, five trials from Germany, four trials from China, four trials from Australia, two trials from Japan, and two trials from the UK; and South Korea, Malaysia, Turkey, and Italy each had one trial. The age of patients ranged from 44.7 to 70.3 years (median 56 years) across all studies, and 92% were female. Breast cancer (20 studies) was the most studied cancer among the enrolled studies, followed by various cancers (seven studies), colorectal cancer (three studies), prostate cancer (one study), lung cancer (one study), hepatic carcinoma (one study), and ovarian cancer (one study). The mean HRQOL score of patients at the baseline of CIM treatment was 82.5 (range 20.7-152.1), while it was 80.4 (range 16.6-143.2) in the control group. However, after treatment, the mean HRQOL score of patients in the CIM group was 87 (range 24.4-145.2), while it was 81.8 (range 20-131.4) in the control group.
Quality assessment and risk of bias of the included trials
Using Cochrane's Risk of Bias assessment tool, the result indicated that 11 studies were scored as high quality. Most studies scored high risk are ascribed to the bias on blinding of personnel, since blinding of personnel was not applicable during the exercise interventions. Furthermore, several studies were judged as unclear risk of bias in random sequence generation, allocation concealment, blinding of participants and personnel, and blinding of outcome assessment. The results are shown in Figure 2 .
Direct meta-analysis of the included studies
After extracting the data of the included studies, available direct comparisons and network of trials were compiled and are shown in Figure 3 . All agents were associated with HRQOL and CIMs compared with placebo/usual care without CIMs. In post-hoc sensitivity analysis using the Hartung-Knapp method, all results were consistent. The results indicated that, taking usual care without CIM treatment as a comparator, all the CIM treatments reported the effects on HRQOL and emotional well-being. Most enrolled studies compared yoga and NS with control on all the treatment efficacy evaluation dimensions, such as HRQOL and emotional well-being. Furthermore, for the change in HRQOL from endpoint to baseline, we used direct metaanalysis and the results showed that all the subgroups of different CIM treatments did not show obvious heterogeneity. Therefore, a fixed-effect model was employed to test the effects. 
Network meta-analysis of the included studies
To further demonstrate the relative effect of each intervention on the HRQOL, network meta-analysis was applied and the ranking probability for each treatment was estimated. Graphical results are shown in Figure 5 . The overall ranks were interpreted by the surface under the cumulative ranking (SUCRA) technique. 61 For HRQOL, , which means that all the treatments are more effective than control ( Figure 5A ). For emotional well-being, the ranking probability was CH > yoga > acupuncture > MCM > NS > MM > massage > qigong > control ( Figure 5B ). For fatigue, the ranking probability was CH > yoga > control > MM > NS > MCM > qigong > acupuncture ( Figure 5C ). For physical well-being, the ranking probability was yoga > MCM > control > NS > acupuncture > massage > MM > qigong ( Figure 5D ). For sleep quality, the ranking probability was control > yoga > qigong > MM > MCM > acupuncture ( Figure 5E ). For social well-being, the ranking probability was control > yoga > NS > MCM > massage > acupuncture > qigong ( Figure 5F ).
Publication bias and network coherence
There was no evidence of publication bias, either qualitatively based on funnel-plot asymmetry ( Figure 6 ) or quantitatively based on Begg's regression test (Figure 7 ) (P>0.05 for all comparisons), although the number of studies included in each comparison was small. Evaluation of the Monte Carlo error suggested adequacy of convergence, which suggested good model fit.
Quality of evidence
The GRADE evidence profiles are shown in Table 3 . The GRADE level of meta-analysis combining direct and indirect evidence was moderate for overall CIM interventions. Regarding each CIM intervention, the GRADE quality of evidence was moderate for NS, yoga, and CH, while it was low for the remaining treatments.
Discussion
As a major global health problem, cancer is a terrible disease in which complications from conventional treatments may reduce the HRQOL, which in turn affects the prognosis of patients. Therefore, more and more clinicians take HRQOL into consideration when establishing a therapeutic regimen to gain an optimal response. In the present meta-analysis, we combined direct and indirect evidence from 34 RCTs in 3,010 patients with tumor to demonstrate the potential advantage of different CIM treatments on the HRQOL. The results tended to provide moderate-quality or low-quality evidence for moderate beneficial effects of CIM interventions on the HRQOL of cancer patients. As a whole, the change in HRQOL scores was statistically significant between CIM treatment (mean range from 82.5 to 87.0) and control (mean range from 80.4 to 81.8) groups. Direct meta-analysis for total effect also showed the clearly superior efficacy of CIM treatments, although subgroup analysis demonstrated that only CH and qigong + MM were significantly favored more than usual care. In this study, yoga was the most studied intervention, with eight trials included in the analysis, followed by NS, CH, and acupuncture. When we searched PubMed briefly with random words we found that the most papers had been published on NS, followed by acupuncture, CH, and yoga, which indicated that studies on acupuncture and CH may focus more on the unambiguous diseases rather than functional discomfort such as HRQOL. However, it may also be due to the complexity of acupuncture and CH, for which it is difficult to make a blank control, an essential requirement for RCTs. [62] [63] [64] Therefore, more RCTs on acupuncture and CH are needed to explore their effects on HRQOL of cancer patients, since they have been elaborately studied in the fields of specific diseases such as cancers. Nearly half of the included studies were conducted in the USA, which may be related to its highly developed medical research. This may influence the conclusions of our study and the multiplicity of study locations serves to increase the level of confidence in our findings.
In 2012, about 14.1 million new cases of cancer were diagnosed worldwide, with the most common types being lung (13%), breast (12%), and colorectal cancer (10%). 65 In our analysis, breast cancer was the most studied cancer and most of the participators (92%) were female, with only one study focusing on the most widespread cancer, ie, lung cancer. Only 8% of the enrolled participants were male, which may reduce the credibility of our conclusions and make it difficult to recommend such CIM interventions among male cancer patients. Therefore, more high-quality RCTs, in greater detail and focusing on various cancers among both female and male patients, are needed and will prove valuable.
Although tests showed the clearly superior efficacy of CIM treatments in improving HRQOL, yoga seems to aggravate sleep quality (SMD −0.81 [−1.18, −0.08]). However, there was only one study reporting the sleep scores after treatment with yoga, so more research is needed to clarify the effects of yoga on sleep quality with more certainty.
Traditional Chinese medicine (TCM) has been long practiced and is becoming ever more widely recognized as providing curative and/or healing treatments for a number of diseases and physiological conditions. 66 CH, acupuncture, and moxibustion are among the most popular types of TCM. CH showed a significantly superior relative effect on HRQOL, emotional well-being, and fatigue. CH is complicated and variable since it often employs combined prescriptions of multiple herbs for disease treatment. 64 Such complexity and variability are based on an empirical set of principles that is referred to as monarch, minister, assistant, and guide. 67 Therefore, only a small number of RCTs on CH have been conducted, most of which are of poor methodological quality owing to difficulties in the design and implementation of placebo-blinded trials. 68 Modernization of CH, such as pharmacological studies including chemistry-focused, target-directed, and systems-biology-based studies, may promote its development. Acupuncture, however, in this analysis, did not show superiority in improving HRQOL. In accord with previous studies, 69 yoga was found to play an important role in both emotional and physical well-being. Although all included studies were RCTs without obvious risks of bias, limitations are present and should be accounted for when interpreting the study's findings. First, only 34 RCTs were included in the present study according to the selected criteria and no more than eight trials were conducted for each CIM intervention. The small sample size limited statistical power and study generalizability, meaning that the actual effects of CIMs may be small, although they showed superior relative effects from the existing data. Individual patient data and more detailed subgroups would have enabled us to provide more detailed insights. So, larger and more diverse samples are needed to calculate the best intervention for the exact tumor type and even the exact domains, such as emotional well-being or sleep quality, to remove the potentially confounding influence of such differences. On the other hand, other psychosocial support services such as music and art therapy or psychological counseling may also make sense, although they are excluded from the present study. The HRQOL of tumor patients is often complex and difficult to resolve, and a consistently effective CIM treatment is still lacking, making it important to examine this in future research. Second, although we have tried to figure out which intervention may be best for HRQOL by ranking the probability for each treatment using ADDIS, there is still a lack of clinical trials comparing the different efficacy of different CIMs. In addition, research focusing more on male cancer patients may make the recommended CIMs more convincing for all cancer patients. More tools which are commonly used in integrative oncology research, such as Measure Yourself Concerns and Wellbeing (MYCaW) 70 and the Edmonton Symptom Assessment Scale (ESAS), 71 may be used in future research.
Conclusion
This systematic review provides a comprehensive overview of the relationship between different CIM interventions and the HRQOL of tumor patients. The results demonstrated clearly superior efficacy of CIM treatments in improving HRQOL, and different CIM interventions may play different roles in HRQOL such as emotional and physical well-being. More studies, especially focusing on male cancer patients, are needed to increase the confidence levels of our findings.
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